DFL24498

· Dompé Farmaceutici S.p.A.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for DFL24498, covering 2026-03-31 to 2026-04-20. Get the full timeline:

Most recent: Clinical Trial Update: An Efficacy and Safety Study of DFL24498 in the Treatment of AKC [Phase 3]